OncoMed Pharmaceuticals, Inc.
     
 
 

Analyst Coverage

Firm Analyst Contact Information
BMO   Ian Somaiya Email
Phone: (212) 885-4038
Cantor Fitzgerald   Mara Goldstein Email
Phone: (212) 610-2215
H.C. Wainwright & Co.   Shaunak K. Deepak Email
Phone: 212.916.3960
Jefferies   Brian Abrahams Email
Phone: (212) 284-2403
JMP Securities   Michael G. King Email
Phone: (212) 906-3520
Leerink Swann   Paul Matteis Email
Phone: (617) 918-4585
Piper Jaffray   Edward A. Tenthoff Email
Phone: (212) 284-9403
SunTrust Robinson Humphrey, Inc.   Peter Lawson, D.Phil Email
Phone: 212-319-3308
Wells Fargo   James W. Birchenough Phone: (415) 645-0800

OncoMed Pharmaceuticals is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding OncoMed Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of OncoMed Pharmaceuticals or its management. OncoMed Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Stock Quote (NASDAQ: OMED)
Price:
4.31
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on Aug 17, 2017
Delayed at least 20 minutes.
Provided by eSignal.
Search Investor Relations